Live
AnaptysBio, Inc.
Healthcare · Biotechnology · NASDAQ
252 candles · 1Y · retrieved ● E = earnings
Fair value withheld
DCF_FCFF: archetype gate · HISTORICAL_PE: archetype gate · PEER_EV_EBITDA: archetype gate · EXCESS_RETURNS: archetype gate · PATH_TO_PROFIT: no growth · DDM: archetype gate · TOTAL_PAYOUT: archetype gate · REIT_OCF: archetype gate
Value
—
Estimate momentum
◆ mixed
Next catalyst
ANAB earnings · 0d
earnings
Volatility
calm
regime
1M forecast
64% up
median +3.6%
Value tells you the size of the gap; the other cells tell you what could close it — and when. A cheap stock without a catalyst can stay cheap.
Probability higher · median +3.6%
80% range -9.4% to 20.3% · confidence 50%
fresh evidence · uncalibrated
No intelligence items published yet.